Repligen (NASDAQ:RGEN) PT Lowered to $165.00
Repligen (NASDAQ:RGEN – Get Rating) had its price target lowered by research analysts at Deutsche Bank Aktiengesellschaft from $180.00 to $165.00 in a report issued on Wednesday, The Fly reports. Deutsche Bank Aktiengesellschaft’s price objective indicates a potential upside of 4.94% from the company’s current price. RGEN has been the subject of several other reports. […]